{
  "slug": "synsorybio",
  "name": "SynsoryBio",
  "yc_id": 29305,
  "batch": "Winter 2024",
  "website": "https://www.synsorybio.com/",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:27:47.450277",
    "website": "https://www.synsorybio.com/",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 1615.52,
      "final_url": "https://www.synsorybio.com/",
      "redirected": false,
      "checked_at": "2025-10-17T01:27:49.065814"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "synsorybio.com",
      "registrar": "NameCheap, Inc.",
      "creation_date": "2023-02-14T21:12:09",
      "expiration_date": "2026-02-14T21:12:09",
      "domain_age_days": 975,
      "domain_age_years": 2.7,
      "name_servers": [
        "DNS1.REGISTRAR-SERVERS.COM",
        "DNS2.REGISTRAR-SERVERS.COM"
      ]
    },
    "social_links": {
      "twitter": null,
      "linkedin": null,
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": false,
      "content_security_policy": true,
      "x_frame_options": true,
      "x_content_type_options": true,
      "x_xss_protection": true,
      "referrer_policy": true,
      "security_score": 83,
      "server": "ESF"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:41:29.295398",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0",
    "model_used": "google/gemini-2.0-flash-001",
    "enriched_at": "2025-10-17T12:41:53.554583",
    "status": "success",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "growing",
      "key_trends": [
        "Precision medicine",
        "Targeted drug delivery",
        "Advancements in protein engineering"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Strong IP around conditional protein activation mechanisms and delivery systems.",
      "differentiation": "Protein therapeutics that activate only at the site of disease, enhancing efficacy and reducing side effects.",
      "competitive_advantages": [
        "Reduced off-target effects",
        "Potential for higher drug potency"
      ],
      "competitive_vulnerabilities": [
        "Complexity of protein engineering",
        "Regulatory hurdles for novel drug mechanisms"
      ]
    },
    "business_model": {
      "revenue_model": "Licensing/Partnerships with pharmaceutical companies",
      "scalability": "high",
      "capital_intensity": "high"
    },
    "growth_assessment": {
      "growth_stage": "seed",
      "growth_indicators": [
        "Preclinical data demonstrating efficacy",
        "Partnerships with research institutions"
      ],
      "growth_bottlenecks": [
        "Securing funding for clinical trials",
        "Scaling up protein production"
      ]
    },
    "risk_analysis": {
      "market_risk": "medium",
      "technology_risk": "high",
      "execution_risk": "medium",
      "overall_risk_score": 7,
      "key_risks": [
        "Clinical trial failures",
        "Competition from established drug delivery methods",
        "Regulatory approval delays"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Novel technology with significant potential",
        "Large addressable market",
        "Strong founding team (assumed)"
      ],
      "concerns": [
        "High capital requirements",
        "Long development timelines"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Companies developing targeted drug delivery systems",
        "Biotech companies focused on protein therapeutics"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Secure seed funding to advance preclinical studies",
        "Develop a robust IP portfolio"
      ],
      "expansion_opportunities": [
        "Explore partnerships with pharmaceutical companies",
        "Expand the platform to other disease areas"
      ]
    },
    "tokens_used": {
      "prompt": 668,
      "completion": 583,
      "total": 1251,
      "estimated_cost": 0.000225
    }
  },
  "phase8_complete": true
}